Back

Heart failure treatment optimization in patients with dystrophin-related muscular dystrophy and HFrEF

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Comorbidities and heart failure therapies Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Luca Monzo

Clinical Investigation Centre Pierre Drouin (CIC-P) INSERM, Vandoeuvre-Les-Nancy (France)

5 More presentations in this session

Presentation thumbnail
Frailty status, aging, and mortality risk in heart failure
Miss C. Garred (Herlev, DK)
Abstract Slides Video
Presentation thumbnail
The impact of malnutrition severity on mortality risk in super-elderly patients with acute heart failure: a Geriatric Nutritional Risk Index-based assessment
Doctor T. Murakami (Maebashi, JP)
Abstract Slides Video
Presentation thumbnail
Incidence and outcomes of dementia after a diagnosis of heart failure: a population-based study
Mr P. Tieu (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Newer GLP-1 receptor agonists and clinical outcomes in heart failure with reduced ejection fraction: a real-world comparative study
Associate Professor A. Kalogeropoulos (Stony Brook, US)
Abstract Slides Video
Presentation thumbnail
Comorbidity burden in patients with cardiogenic shock: a cardiogenic shock working group analysis
Doctor J. Sundermeyer (Hamburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Comorbidities and heart failure therapies
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Dilated cardiomyopathy as the initial presentation of becker muscular dystrophy
thumbnail
Congress Presentation
Contemporary patient characterization and implementation of medical therapy for heart failure across the ejection fraction spectrum: the OPTIPHARM-HF registry
thumbnail
Congress Presentation
A journey through the aetiological work-up of the Dilative Cardiomyopathy: a case of cardiac involvement by Glycogenosis.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources